Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (241-250 of 397) with videos related to

Pageof 40
Sort By:
The Cochrane Database of Systematic Reviews|April 30, 2016
Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugsLucy Platt, Jennifer Reed, Silvia Minozzi, et al.
AIDS (London, England)|January 29, 2014
Exploring the population-level impact of antiretroviral treatment: the influence of baseline intervention contextSharmistha Mishra, Elisa Mountain, Michael Pickles, et al.
Journal of Viral Hepatitis|November 8, 2023
Incidence of hepatitis C virus infection in the prison setting: The SToP-C studyBehzad Hajarizadeh, Joanne M Carson, Marianne Byrne, et al.
Open Forum Infectious Diseases|September 29, 2021
Elucidating Drivers for Variations in the Explosive Human Immunodeficiency Virus Epidemic Among People Who Inject Drugs in PakistanAaron G Lim, Adam Trickey, Laura H Thompson, et al.
AIDS (London, England)|December 23, 2008
Using mathematical modelling to investigate the plausibility of attributing observed antenatal clinic declines to a female sex worker intervention in Karnataka state, IndiaMarie-Claude Boily, Michael Pickles, Peter Vickerman, et al.
Lancet Regional Health. Americas|February 8, 2024
Cost-effectiveness of a police education program on HIV and overdose among people who inject drugs in Tijuana, MexicoJavier A Cepeda, Leo Beletsky, Daniela Abramovitz, et al.
The Lancet. Gastroenterology & Hepatology|December 16, 2024
Elimination of hepatitis B requires recognition of catastrophic costs for patients and their familiesJulie Jemutai, Louise Downs, Motswedi Anderson, et al.
The Lancet. Global Health|January 25, 2025
Tuberculosis and people who use drugs: why focus on this overlooked population is important and why adapted interventions are necessaryMorgana D'Ottavi, Peter Godfrey-Faussett, Corinne S Merle, et al.
Harm Reduction Journal|May 25, 2018
Cost of provision of opioid substitution therapy provision in Tijuana, MexicoJose Luis Burgos, Javier A Cepeda, James G Kahn, et al.
Hepatology (Baltimore, Md.)|April 5, 2013
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antiviralsNatasha K Martin, Peter Vickerman, Jason Grebely, et al.
Pageof 40

Showing results (241-250 of 397) with videos related to

Sort By:
Pageof 40
The Cochrane Database of Systematic Reviews|April 30, 2016
Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugsLucy Platt, Jennifer Reed, Silvia Minozzi, et al.
AIDS (London, England)|January 29, 2014
Exploring the population-level impact of antiretroviral treatment: the influence of baseline intervention contextSharmistha Mishra, Elisa Mountain, Michael Pickles, et al.
Journal of Viral Hepatitis|November 8, 2023
Incidence of hepatitis C virus infection in the prison setting: The SToP-C studyBehzad Hajarizadeh, Joanne M Carson, Marianne Byrne, et al.
Open Forum Infectious Diseases|September 29, 2021
Elucidating Drivers for Variations in the Explosive Human Immunodeficiency Virus Epidemic Among People Who Inject Drugs in PakistanAaron G Lim, Adam Trickey, Laura H Thompson, et al.
AIDS (London, England)|December 23, 2008
Using mathematical modelling to investigate the plausibility of attributing observed antenatal clinic declines to a female sex worker intervention in Karnataka state, IndiaMarie-Claude Boily, Michael Pickles, Peter Vickerman, et al.
Lancet Regional Health. Americas|February 8, 2024
Cost-effectiveness of a police education program on HIV and overdose among people who inject drugs in Tijuana, MexicoJavier A Cepeda, Leo Beletsky, Daniela Abramovitz, et al.
The Lancet. Gastroenterology & Hepatology|December 16, 2024
Elimination of hepatitis B requires recognition of catastrophic costs for patients and their familiesJulie Jemutai, Louise Downs, Motswedi Anderson, et al.
The Lancet. Global Health|January 25, 2025
Tuberculosis and people who use drugs: why focus on this overlooked population is important and why adapted interventions are necessaryMorgana D'Ottavi, Peter Godfrey-Faussett, Corinne S Merle, et al.
Harm Reduction Journal|May 25, 2018
Cost of provision of opioid substitution therapy provision in Tijuana, MexicoJose Luis Burgos, Javier A Cepeda, James G Kahn, et al.
Hepatology (Baltimore, Md.)|April 5, 2013
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antiviralsNatasha K Martin, Peter Vickerman, Jason Grebely, et al.
Pageof 40